Karin Fjordén

1PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 26, 2021
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial.

Karin Fjordén, Sara Ekberg, Nevzeta Kuric

Pageof 1

Frequent Collaborators

1 joint publications

Sara Ekberg

1 joint publications

Ingemar Lagerlöf